STERIS (STE)

As of 30 September 2026, short interest in STE is 2,857,327 shares, up 413,662 shares over the last month. Over the last 48 readings it ranged from 728,308 shares (13 June 2025) to 3,159,401 shares (31 July 2026). At the reported average volume of 688K shares a day that is 4.2 days to cover.

<iframe src="https://xoomar.com/embed/stocks/ste" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>

As of 9 October 2026, the short share of STE volume is 67.8%, down 1.6 points over the last five sessions. Over the last 30 readings it ranged from 46.9% (21 September 2026) to 80.6% (15 September 2026). The latest reading is 2.9 points above the 30-session average of 64.9%, on 225K shares reported.

As of 25 August 2026, the fails-to-deliver balance in STE is 1 share, down 15 shares over the last settlement date. Over the last 30 readings it ranged from 1 share (25 August 2026) to 28,796 shares (13 February 2026). The latest reading sits at the bottom of that range.

Insiders at STE reported 1 open-market sell worth $957K in the last 90 days and no open-market buys. Latest filing: Burton Karen L (Sr. Vice Pres., CFO) on 2026-10-01.

Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.

11 Form 144 notices on file for STE worth $10.8M at the prices reported; 2 in the last 90 days worth $1.9M. Latest: Breeden Richard C filed on 2026-08-18 to sell 4,110 shares ($953K) from 2026-08-18.

3 holders report 5% or more of STE in their latest filing, all on Schedule 13G (passive). The largest reported stake is Vanguard Capital Management at 7.5% of the class (7,340,236 shares), filed 2026-04-30 for an event on 2026-03-31.

7 of the 30 tracked managers held STE at their latest 13F, $564.9M in total at quarter-end prices. AQR Capital Management is the largest at $285.8M (0.1% of its portfolio) as of 2026-06-30. Over the prior quarter 5 added shares and 2 cut.

Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.

In Q1 FY 2027 (quarter ended 2026-06-30) STERIS reported revenue of $1.49B, up 7.3% from the same quarter a year earlier, and net income of $200.1M. In FY 2026 it generated $1.34B of operating cash flow and spent $235.5M on buybacks and $241.8M on dividends. As of 2026-06-30, cash was $482.3M against $1.65B of debt.

Quarterly, last 8 quarters

Fiscal years, with buybacks and dividends

Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-08-04 from the cover page.